The global pharmaceutical landscape is undergoing a significant shift toward expanded accessibility for complex biologic therapies, highlighted by a major…
Read More
DFE Pharma Expands Continuous Manufacturing Capabilities to Address Industry-Wide Adoption Challenges in Pharmaceutical Production
The global pharmaceutical manufacturing sector is undergoing a profound paradigm shift, moving steadily away from traditional batch processing toward continuous…
Read More
Beijing Unveils Blueprint for Biomedical Dominance by 2030
The municipal government of Beijing has officially released a comprehensive strategic roadmap aimed at establishing the Chinese capital as a…
Read More
Telix Pharmaceuticals Agrees to Acquire ITM Isotope Technologies Munich in Landmark $2.35bn Radiopharmaceutical Megamerger
Australia-based radiopharmaceutical leader Telix Pharmaceuticals has entered into a definitive agreement to acquire Germany’s ITM Isotope Technologies Munich in a…
Read More
FDA Public Hearing Examines the Future of Psychedelic Therapeutics and Balanced Regulatory Pathways
On September 14, the United States Food and Drug Administration (FDA) convened a landmark public hearing to address the evolving…
Read More
The Shrinking Return on Investment for Nordic Innovation in the Global Pharmaceutical Sector
The Nordic region—historically celebrated as a powerhouse of life sciences, medical research, and biotechnology innovation—is currently confronting a complex economic…
Read More
Roche and Dualitas Therapeutics Ink Billion-Dollar Partnership to Advance Next-Generation Bispecific Antibodies in Immunology and Inflammation
In a landmark agreement that underscores the surging therapeutic potential of proximity biology, Swiss pharmaceutical giant Roche has joined forces…
Read More
WuXi XDC and Ona Therapeutics Expand Partnership Through Exclusive Global Licensing Agreement for Advanced Antibody-Drug Conjugate Platform
In a significant expansion of their ongoing strategic partnership, WuXi XDC Cayman has entered into an exclusive global licensing agreement…
Read More
FDA Approves Ultragenyx Gene Therapy Fayuvi for Sanfilippo Syndrome Type A at a Record-Breaking $3.95m Price Tag
In a landmark decision for pediatric neurology and rare disease research, the US Food and Drug Administration (FDA) has granted…
Read More
Novo Secures $1.4bn Partnership With Orbis Medicines to Bolster Cardiometabolic Pipeline Through AI-Driven Macrocycle Therapeutics
In a strategic move to fortify its cardiovascular and metabolic disease pipeline following a sequence of high-profile clinical and commercial…
Read More
